<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20241211072211&amp;utm_medium=rss&amp;fc=20230708114047&amp;utm_source=Chrome&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;v=2.18.0.post9+e462414&amp;utm_campaign=pubmed-2
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20241211072211&amp;utm_medium=rss&amp;fc=20230708114047&amp;utm_source=Chrome&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;v=2.18.0.post9+e462414&amp;utm_campaign=pubmed-2" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Wed, 11 Dec 2024 12:22:12 +0000</lastbuilddate>
<pubDate>Wed, 11 Dec 2024 06:00:00 -0500</pubDate>
<ttl>120</ttl>
<item>
<title>Illuminating data: how the new ESC Atlas can help chart a healthier future across Europe</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39660413/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241211072211&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Dec 11:ehae865. doi: 10.1093/eurheartj/ehae865. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39660413/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241211072211&v=2.18.0.post9+e462414">39660413</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae865>10.1093/eurheartj/ehae865</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39660413</guid>
<pubDate>Wed, 11 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Judith Ozkan</dc:creator>
<dc:date>2024-12-11</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Illuminating data: how the new ESC Atlas can help chart a healthier future across Europe</dc:title>
<dc:identifier>pmid:39660413</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae865</dc:identifier>
</item>
<item>
<title>Type 2 myocardial infarction: challenges in diagnosis and treatment</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39658094/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241211072211&amp;v=2.18.0.post9+e462414
      <description>The Fourth Universal Definition of Myocardial Infarction recommends a classification based on aetiology, in recognition that the underlying pathophysiology of myocardial infarction influences the approach to investigation and treatment. Type 1 myocardial infarction occurs due to atherosclerotic plaque rupture with thrombosis, whereas type 2 myocardial infarction occurs due to an imbalance in myocardial oxygen supply or unmet need in myocardial oxygen demand, without atherothrombosis, usually in...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Dec 10:ehae803. doi: 10.1093/eurheartj/ehae803. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The Fourth Universal Definition of Myocardial Infarction recommends a classification based on aetiology, in recognition that the underlying pathophysiology of myocardial infarction influences the approach to investigation and treatment. Type 1 myocardial infarction occurs due to atherosclerotic plaque rupture with thrombosis, whereas type 2 myocardial infarction occurs due to an imbalance in myocardial oxygen supply or unmet need in myocardial oxygen demand, without atherothrombosis, usually in the context of another acute illness. In this state-of-the-art review, the diagnosis, investigation, and treatment of patients with type 2 myocardial infarction are considered, with general advice for clinical practice and a consideration of future research directions.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39658094/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241211072211&v=2.18.0.post9+e462414">39658094</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae803>10.1093/eurheartj/ehae803</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39658094</guid>
<pubDate>Tue, 10 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Andrew R Chapman</dc:creator>
<dc:creator>Caelan Taggart</dc:creator>
<dc:creator>Jasper Boeddinghaus</dc:creator>
<dc:creator>Nicholas L Mills</dc:creator>
<dc:creator>Keith A A Fox</dc:creator>
<dc:date>2024-12-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Type 2 myocardial infarction: challenges in diagnosis and treatment</dc:title>
<dc:identifier>pmid:39658094</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae803</dc:identifier>
</item>
<item>
<title>Gold standard: Peter J. Schwartz honoured for pioneering work</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39658031/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241211072211&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Dec 10:ehae777. doi: 10.1093/eurheartj/ehae777. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39658031/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241211072211&v=2.18.0.post9+e462414">39658031</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae777>10.1093/eurheartj/ehae777</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39658031</guid>
<pubDate>Tue, 10 Dec 2024 06:00:00 -0500</pubDate>
<dc:date>2024-12-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Gold standard: Peter J. Schwartz honoured for pioneering work</dc:title>
<dc:identifier>pmid:39658031</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae777</dc:identifier>
</item>
<item>
<title>AI-ECG and prediction of new atrial fibrillation: when the heart tells the age</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39657904/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241211072211&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Dec 9:ehae809. doi: 10.1093/eurheartj/ehae809. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39657904/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241211072211&v=2.18.0.post9+e462414">39657904</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae809>10.1093/eurheartj/ehae809</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39657904</guid>
<pubDate>Tue, 10 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Antonio H Ribeiro</dc:creator>
<dc:creator>Antonio Luiz P Ribeiro</dc:creator>
<dc:date>2024-12-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>AI-ECG and prediction of new atrial fibrillation: when the heart tells the age</dc:title>
<dc:identifier>pmid:39657904</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae809</dc:identifier>
</item>
<item>
<title>Left Ventricular Ejection Fraction and Implantable Cardioverter-Defibrillator in Non-ischemic Heart Failure with Reduced Ejection Fraction: Insights from DANISH</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39657767/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241211072211&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Dec 10. doi: 10.1161/CIRCULATIONAHA.124.071777. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39657767/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241211072211&v=2.18.0.post9+e462414">39657767</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.071777>10.1161/CIRCULATIONAHA.124.071777</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39657767</guid>
<pubDate>Tue, 10 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Seiko N Doi</dc:creator>
<dc:creator>Jawad H Butt</dc:creator>
<dc:creator>Jens Jakob Thune</dc:creator>
<dc:creator>Jens C Nielsen</dc:creator>
<dc:creator>Jens Haarbo</dc:creator>
<dc:creator>Niels E Bruun</dc:creator>
<dc:creator>Line L Olesen</dc:creator>
<dc:creator>Lars Videbæk</dc:creator>
<dc:creator>Finn Gustafsson</dc:creator>
<dc:creator>Hans Eiskjær</dc:creator>
<dc:creator>Christian Hassager</dc:creator>
<dc:creator>Jesper H Svendsen</dc:creator>
<dc:creator>Dan E Høfsten</dc:creator>
<dc:creator>Steen Pehrson</dc:creator>
<dc:creator>Lars Køber</dc:creator>
<dc:date>2024-12-10</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Left Ventricular Ejection Fraction and Implantable Cardioverter-Defibrillator in Non-ischemic Heart Failure with Reduced Ejection Fraction: Insights from DANISH</dc:title>
<dc:identifier>pmid:39657767</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.071777</dc:identifier>
</item>
<item>
<title>Dual BACH1 regulation by complementary SCF-type E3 ligases</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39657677/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241211072211&amp;v=2.18.0.post9+e462414
      <description>Broad-complex, tramtrack, and bric-à-brac domain (BTB) and CNC homolog 1 (BACH1) is a key regulator of the cellular oxidative stress response and an oncogene that undergoes tight post-translational control by two distinct F-box ubiquitin ligases, SCF^(FBXO22) and SCF^(FBXL17). However, how both ligases recognize BACH1 under oxidative stress is unclear. In our study, we elucidate the mechanism by which FBXO22 recognizes a quaternary degron in a domain-swapped β-sheet of the BACH1 BTB dimer....</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Dec 6:S0092-8674(24)01322-9. doi: 10.1016/j.cell.2024.11.006. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Broad-complex, tramtrack, and bric-à-brac domain (BTB) and CNC homolog 1 (BACH1) is a key regulator of the cellular oxidative stress response and an oncogene that undergoes tight post-translational control by two distinct F-box ubiquitin ligases, SCF<sup>FBXO22</sup> and SCF<sup>FBXL17</sup>. However, how both ligases recognize BACH1 under oxidative stress is unclear. In our study, we elucidate the mechanism by which FBXO22 recognizes a quaternary degron in a domain-swapped β-sheet of the BACH1 BTB dimer. Cancer-associated mutations and cysteine modifications destabilize the degron and impair FBXO22 binding but simultaneously expose an otherwise shielded degron in the dimer interface, allowing FBXL17 to recognize BACH1 as a monomer. These findings shed light on a ligase switch mechanism that enables post-translational regulation of BACH1 by complementary ligases depending on the stability of its BTB domain. Our results provide mechanistic insights into the oxidative stress response and may spur therapeutic approaches for targeting oxidative stress-related disorders and cancer.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39657677/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241211072211&v=2.18.0.post9+e462414">39657677</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.11.006>10.1016/j.cell.2024.11.006</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39657677</guid>
<pubDate>Tue, 10 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Benedikt Goretzki</dc:creator>
<dc:creator>Maryam Khoshouei</dc:creator>
<dc:creator>Martin Schröder</dc:creator>
<dc:creator>Patrick Penner</dc:creator>
<dc:creator>Luca Egger</dc:creator>
<dc:creator>Christine Stephan</dc:creator>
<dc:creator>Dayana Argoti</dc:creator>
<dc:creator>Nele Dierlamm</dc:creator>
<dc:creator>Jimena Maria Rada</dc:creator>
<dc:creator>Sandra Kapps</dc:creator>
<dc:creator>Catrin Swantje Müller</dc:creator>
<dc:creator>Zacharias Thiel</dc:creator>
<dc:creator>Merve Mutlu</dc:creator>
<dc:creator>Claude Tschopp</dc:creator>
<dc:creator>David Furkert</dc:creator>
<dc:creator>Felix Freuler</dc:creator>
<dc:creator>Simon Haenni</dc:creator>
<dc:creator>Laurent Tenaillon</dc:creator>
<dc:creator>Britta Knapp</dc:creator>
<dc:creator>Alexandra Hinniger</dc:creator>
<dc:creator>Philipp Hoppe</dc:creator>
<dc:creator>Enrico Schmidt</dc:creator>
<dc:creator>Sascha Gutmann</dc:creator>
<dc:creator>Mario Iurlaro</dc:creator>
<dc:creator>Grigory Ryzhakov</dc:creator>
<dc:creator>César Fernández</dc:creator>
<dc:date>2024-12-10</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Dual BACH1 regulation by complementary SCF-type E3 ligases</dc:title>
<dc:identifier>pmid:39657677</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.11.006</dc:identifier>
</item>
<item>
<title>A commonly inherited human PCSK9 germline variant drives breast cancer metastasis via LRP1 receptor</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39657676/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241211072211&amp;v=2.18.0.post9+e462414
      <description>Identifying patients at risk for metastatic relapse is a critical medical need. We identified a common missense germline variant in proprotein convertase subtilisin/kexin type 9 (PCSK9) (rs562556, V474I) that is associated with reduced survival in multiple breast cancer patient cohorts. Genetic modeling of this gain-of-function single-nucleotide variant in mice revealed that it causally promotes breast cancer metastasis. Conversely, host PCSK9 deletion reduced metastatic colonization in multiple...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Dec 7:S0092-8674(24)01326-6. doi: 10.1016/j.cell.2024.11.009. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Identifying patients at risk for metastatic relapse is a critical medical need. We identified a common missense germline variant in proprotein convertase subtilisin/kexin type 9 (PCSK9) (rs562556, V474I) that is associated with reduced survival in multiple breast cancer patient cohorts. Genetic modeling of this gain-of-function single-nucleotide variant in mice revealed that it causally promotes breast cancer metastasis. Conversely, host PCSK9 deletion reduced metastatic colonization in multiple breast cancer models. Host PCSK9 promoted metastatic initiation events in lung and enhanced metastatic proliferative competence by targeting tumoral low-density lipoprotein receptor related protein 1 (LRP1) receptors, which repressed metastasis-promoting genes XAF1 and USP18. Antibody-mediated therapeutic inhibition of PCSK9 suppressed breast cancer metastasis in multiple models. In a large Swedish early-stage breast cancer cohort, rs562556 homozygotes had a 22% risk of distant metastatic relapse at 15 years, whereas non-homozygotes had a 2% risk. Our findings reveal that a commonly inherited genetic alteration governs breast cancer metastasis and predicts survival-uncovering a hereditary basis underlying breast cancer metastasis.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39657676/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241211072211&v=2.18.0.post9+e462414">39657676</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.11.009>10.1016/j.cell.2024.11.009</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39657676</guid>
<pubDate>Tue, 10 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Wenbin Mei</dc:creator>
<dc:creator>Schayan Faraj Tabrizi</dc:creator>
<dc:creator>Christopher Godina</dc:creator>
<dc:creator>Anthea F Lovisa</dc:creator>
<dc:creator>Karolin Isaksson</dc:creator>
<dc:creator>Helena Jernström</dc:creator>
<dc:creator>Sohail F Tavazoie</dc:creator>
<dc:date>2024-12-10</dc:date>
<dc:source>Cell</dc:source>
<dc:title>A commonly inherited human PCSK9 germline variant drives breast cancer metastasis via LRP1 receptor</dc:title>
<dc:identifier>pmid:39657676</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.11.009</dc:identifier>
</item>
<item>
<title>Focus on atrial fibrillation: role of atrioventricular node ablation, prediction by deep learning, and anticoagulation in device-detected arrhythmia</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39657597/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241211072211&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Dec 7;45(46):4873-4877. doi: 10.1093/eurheartj/ehae826.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39657597/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241211072211&v=2.18.0.post9+e462414">39657597</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae826>10.1093/eurheartj/ehae826</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39657597</guid>
<pubDate>Tue, 10 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Filippo Crea</dc:creator>
<dc:date>2024-12-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Focus on atrial fibrillation: role of atrioventricular node ablation, prediction by deep learning, and anticoagulation in device-detected arrhythmia</dc:title>
<dc:identifier>pmid:39657597</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae826</dc:identifier>
</item>
<item>
<title>A Manifesto from Global Heart Hub for early detection and diagnosis of cardiovascular disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39656480/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241211072211&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Dec 3:ehae455. doi: 10.1093/eurheartj/ehae455. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39656480/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241211072211&v=2.18.0.post9+e462414">39656480</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae455>10.1093/eurheartj/ehae455</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39656480</guid>
<pubDate>Tue, 10 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Fausto J Pinto</dc:creator>
<dc:creator>Ed Harding</dc:creator>
<dc:creator>Olive Fenton</dc:creator>
<dc:date>2024-12-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>A Manifesto from Global Heart Hub for early detection and diagnosis of cardiovascular disease</dc:title>
<dc:identifier>pmid:39656480</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae455</dc:identifier>
</item>
<item>
<title>Target 130/80: a future-focused initiative for hypertension management in Azerbaijan</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39656478/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241211072211&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Dec 3:ehae749. doi: 10.1093/eurheartj/ehae749. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39656478/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241211072211&v=2.18.0.post9+e462414">39656478</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae749>10.1093/eurheartj/ehae749</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39656478</guid>
<pubDate>Tue, 10 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Ulvi Mirzoyev</dc:creator>
<dc:date>2024-12-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Target 130/80: a future-focused initiative for hypertension management in Azerbaijan</dc:title>
<dc:identifier>pmid:39656478</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae749</dc:identifier>
</item>
<item>
<title>The Ulysses syndrome of the patient with chronic coronary syndrome</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39656477/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241211072211&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Dec 3:ehae796. doi: 10.1093/eurheartj/ehae796. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39656477/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241211072211&v=2.18.0.post9+e462414">39656477</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae796>10.1093/eurheartj/ehae796</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39656477</guid>
<pubDate>Tue, 10 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Eugenio Picano</dc:creator>
<dc:date>2024-12-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>The Ulysses syndrome of the patient with chronic coronary syndrome</dc:title>
<dc:identifier>pmid:39656477</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae796</dc:identifier>
</item>
<item>
<title>Gold standard: Milton Packer honoured for pioneering work</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39656466/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241211072211&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Dec 3:ehae723. doi: 10.1093/eurheartj/ehae723. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39656466/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241211072211&v=2.18.0.post9+e462414">39656466</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae723>10.1093/eurheartj/ehae723</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39656466</guid>
<pubDate>Tue, 10 Dec 2024 06:00:00 -0500</pubDate>
<dc:date>2024-12-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Gold standard: Milton Packer honoured for pioneering work</dc:title>
<dc:identifier>pmid:39656466</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae723</dc:identifier>
</item>
<item>
<title>European Research Council-funded grant: development of a novel cardiac tissue model</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39656453/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241211072211&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Dec 3:ehae740. doi: 10.1093/eurheartj/ehae740. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39656453/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241211072211&v=2.18.0.post9+e462414">39656453</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae740>10.1093/eurheartj/ehae740</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39656453</guid>
<pubDate>Tue, 10 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Gerardina Ruocco</dc:creator>
<dc:creator>Daniele Testore</dc:creator>
<dc:creator>Valeria Chiono</dc:creator>
<dc:date>2024-12-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>European Research Council-funded grant: development of a novel cardiac tissue model</dc:title>
<dc:identifier>pmid:39656453</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae740</dc:identifier>
</item>
<item>
<title>Endothelial FUNDC1 Deficiency Drives Pulmonary Hypertension</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39655444/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241211072211&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Collectively, we show that FUNDC1-mediated basal mitophagy is critical for endothelial homeostasis, and its disruption instigates PH pathogenesis. Given that similar changes in FUNDC1 and IGFBP2 were observed in PH patients, our findings are of significant clinical relevance and provide novel therapeutic strategies for PH.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 Dec 10. doi: 10.1161/CIRCRESAHA.124.325156. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Pulmonary hypertension (PH) is associated with endothelial dysfunction. However, the cause of endothelial dysfunction and its impact on PH remain incompletely understood. We aimed to investigate whether the hypoxia-inducible FUNDC1 (FUN14 domain-containing 1)-dependent mitophagy pathway underlies PH pathogenesis and progression.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: We first analyzed FUNDC1 protein levels in lung samples from patients with PH and animal models. Using rodent PH models induced by HySu (hypoxia+SU5416) or chronic hypoxia, we further investigated PH pathogenesis and development in response to global and cell-type-specific <i>Fundc1</i> loss/gain-of-function. We also investigated the spontaneous PH in mice with inducible loss of endothelial <i>Fundc1</i>. In addition, histological, metabolic, and transcriptomic studies were performed to delineate molecular mechanisms. Finally, findings were validated in vivo by compound deficiency of HIF2α (hypoxia-inducible factor 2α; <i>Epas1</i>) and pharmacological intervention.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: FUNDC1 protein levels were reduced in PH lung vessels from clinical subjects and animal models. Global <i>Fundc1</i> deficiency exacerbated PH, while its overexpression is protective. The effect of FUNDC1 was mediated by endothelial cells rather than smooth muscle cells. Further, inducible loss of endothelial <i>Fundc1</i> in postnatal mice was sufficient to cause PH spontaneously, whereas augmenting endothelial <i>Fundc1</i> protected against PH before and after the onset of disease. Mechanistically, <i>Fundc1</i> deficiency impaired basal mitophagy in endothelial cells, leading to the accumulation of dysfunctional mitochondria, metabolic reprogramming toward aerobic glycolysis, pseudohypoxia, and senescence, likely via a mtROS-HIF2α signaling pathway. Subsequently, <i>Fundc1</i>-deficient endothelial cells increased IGFBP2 (insulin-like growth factor-binding protein 2) secretion that drove pulmonary arterial remodeling to instigate PH. Finally, proof-of-principle in vivo studies showed significant efficacy on PH amelioration by targeting endothelial mitophagy, pseudohypoxia, senescence, or IGFBP2.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Collectively, we show that FUNDC1-mediated basal mitophagy is critical for endothelial homeostasis, and its disruption instigates PH pathogenesis. Given that similar changes in FUNDC1 and IGFBP2 were observed in PH patients, our findings are of significant clinical relevance and provide novel therapeutic strategies for PH.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39655444/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241211072211&v=2.18.0.post9+e462414">39655444</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.325156>10.1161/CIRCRESAHA.124.325156</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39655444</guid>
<pubDate>Tue, 10 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Yandong Pei</dc:creator>
<dc:creator>Dongfeng Ren</dc:creator>
<dc:creator>Yuanhao Yin</dc:creator>
<dc:creator>Jiajia Shi</dc:creator>
<dc:creator>Qianyuan Ai</dc:creator>
<dc:creator>Wenxin Hao</dc:creator>
<dc:creator>Xiaofan Luo</dc:creator>
<dc:creator>Chenyue Zhang</dc:creator>
<dc:creator>Yanping Zhao</dc:creator>
<dc:creator>Chenyu Bai</dc:creator>
<dc:creator>Lin Zhu</dc:creator>
<dc:creator>Qiong Wang</dc:creator>
<dc:creator>Shuangling Li</dc:creator>
<dc:creator>Yuwei Zhang</dc:creator>
<dc:creator>Jiangtao Lu</dc:creator>
<dc:creator>Lin Liu</dc:creator>
<dc:creator>Lin Zhou</dc:creator>
<dc:creator>Yuli Wu</dc:creator>
<dc:creator>Yiqi Weng</dc:creator>
<dc:creator>Yongle Jing</dc:creator>
<dc:creator>Chengzhi Lu</dc:creator>
<dc:creator>Yujie Cui</dc:creator>
<dc:creator>Hao Zheng</dc:creator>
<dc:creator>Yanjun Li</dc:creator>
<dc:creator>Guo Chen</dc:creator>
<dc:creator>Gang Hu</dc:creator>
<dc:creator>Quan Chen</dc:creator>
<dc:creator>Xudong Liao</dc:creator>
<dc:date>2024-12-10</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Endothelial FUNDC1 Deficiency Drives Pulmonary Hypertension</dc:title>
<dc:identifier>pmid:39655444</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.325156</dc:identifier>
</item>
<item>
<title>Inositol 1,4,5-Trisphosphate Receptor 1 Gain-of-Function Increases the Risk for Cardiac Arrhythmias in Mice and Humans</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39655431/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241211072211&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Our studies in mice and humans reveal that enhanced function of ITPR1, a well-known movement disorder gene, increases the risk for cardiac arrhythmias.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Dec 10. doi: 10.1161/CIRCULATIONAHA.124.070563. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Ca<sup>2+</sup> mishandling in cardiac Purkinje cells is a well-known cause of cardiac arrhythmias. The Purkinje cell resident inositol 1,4,5-trisphosphate receptor 1 (ITPR1) is believed to play an important role in Ca<sup>2+</sup> handling, and ITPR1 gain-of-function (GOF) has been implicated in cardiac arrhythmias. However, nearly all known disease-associated ITPR1 variants are loss-of-function and are primarily linked to neurological disorders. Whether ITPR1 GOF has pathological consequences, such as cardiac arrhythmias, is unclear. This study aimed to identify human ITPR1 GOF variants and determine the impact of ITPR1 GOF on Ca<sup>2+</sup> handling and arrhythmia susceptibility.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: There are a large number of rare ITPR1 missense variants reported in open data repositories. Based on their locations in the ITPR1 channel structure, we selected and characterized 33 human ITPR1 missense variants from open databases and identified 21 human ITPR1 GOF variants. We generated a mouse model carrying a human ITPR1 GOF variant, ITPR1-W1457G (W1447G in mice).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: We showed that the ITPR1-W1447G<sup>±</sup> and recently reported ITPR1-D2594K<sup>±</sup> GOF mutant mice were susceptible to stress-induced ventricular arrhythmias. Confocal Ca<sup>2+</sup> and voltage imaging in situ in heart slices and Ca<sup>2+</sup> imaging and patch-clamp recordings of isolated Purkinje cells showed that ITPR1-W1447G<sup>±</sup> and ITPR1-D2594K<sup>±</sup> variants increased the occurrence of stress-induced spontaneous Ca<sup>2+</sup> release, delayed afterdepolarization, and triggered activity in Purkinje cells. To assess the potential role of ITPR1 variants in arrhythmia susceptibility in humans, we looked up a gene-based association study in the UK Biobank data set and identified 7 rare ITPR1 missense variants showing potential association with cardiac arrhythmias. Remarkably, in vitro functional characterization revealed that all these 7 ITPR1 variants resulted in GOF.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Our studies in mice and humans reveal that enhanced function of ITPR1, a well-known movement disorder gene, increases the risk for cardiac arrhythmias.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39655431/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241211072211&v=2.18.0.post9+e462414">39655431</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.070563>10.1161/CIRCULATIONAHA.124.070563</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39655431</guid>
<pubDate>Tue, 10 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Bo Sun</dc:creator>
<dc:creator>Mingke Ni</dc:creator>
<dc:creator>Yanhui Li</dc:creator>
<dc:creator>Zhenpeng Song</dc:creator>
<dc:creator>Hui Wang</dc:creator>
<dc:creator>Hai-Lei Zhu</dc:creator>
<dc:creator>Jinhong Wei</dc:creator>
<dc:creator>Darrell Belke</dc:creator>
<dc:creator>Shitian Cai</dc:creator>
<dc:creator>Wenting Guo</dc:creator>
<dc:creator>Jinjing Yao</dc:creator>
<dc:creator>Shanshan Tian</dc:creator>
<dc:creator>John Paul Estillore</dc:creator>
<dc:creator>Ruiwu Wang</dc:creator>
<dc:creator>Mads Toft Sondergaard</dc:creator>
<dc:creator>Malene Brohus</dc:creator>
<dc:creator>Palle Duun Rohde</dc:creator>
<dc:creator>Yongxin Mu</dc:creator>
<dc:creator>Alexander Vallmitjana</dc:creator>
<dc:creator>Raul Benitez</dc:creator>
<dc:creator>Leif Hove-Madsen</dc:creator>
<dc:creator>Michael Toft Overgaard</dc:creator>
<dc:creator>Glenn I Fishman</dc:creator>
<dc:creator>Ju Chen</dc:creator>
<dc:creator>Shubhayan Sanatani</dc:creator>
<dc:creator>Arthur A M Wilde</dc:creator>
<dc:creator>Michael Fill</dc:creator>
<dc:creator>Josefina Ramos-Franco</dc:creator>
<dc:creator>Mette Nyegaard</dc:creator>
<dc:creator>S R Wayne Chen</dc:creator>
<dc:date>2024-12-10</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Inositol 1,4,5-Trisphosphate Receptor 1 Gain-of-Function Increases the Risk for Cardiac Arrhythmias in Mice and Humans</dc:title>
<dc:identifier>pmid:39655431</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.070563</dc:identifier>
</item>
<item>
<title>Pro-arrhythmic potential of proton-pump inhibitors</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39653788/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241211072211&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2024 Dec 9. doi: 10.1038/s41569-024-01107-w. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39653788/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241211072211&v=2.18.0.post9+e462414">39653788</a> | DOI:<a href=https://doi.org/10.1038/s41569-024-01107-w>10.1038/s41569-024-01107-w</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39653788</guid>
<pubDate>Mon, 09 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Pietro Enea Lazzerini</dc:creator>
<dc:creator>Riccardo Accioli</dc:creator>
<dc:creator>Pier Leopoldo Capecchi</dc:creator>
<dc:creator>Maurizio Acampa</dc:creator>
<dc:date>2024-12-09</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>Pro-arrhythmic potential of proton-pump inhibitors</dc:title>
<dc:identifier>pmid:39653788</dc:identifier>
<dc:identifier>doi:10.1038/s41569-024-01107-w</dc:identifier>
</item>
<item>
<title>Cognitive Dysfunction in Heart Failure With Preserved Ejection Fraction: Uncovering the Consequences of an Overlooked Comorbidity</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39652649/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241211072211&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Dec 10;150(24):1928-1930. doi: 10.1161/CIRCULATIONAHA.124.072220. Epub 2024 Dec 9.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39652649/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241211072211&v=2.18.0.post9+e462414">39652649</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.072220>10.1161/CIRCULATIONAHA.124.072220</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39652649</guid>
<pubDate>Mon, 09 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Jesús Álvarez-García</dc:creator>
<dc:date>2024-12-09</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Cognitive Dysfunction in Heart Failure With Preserved Ejection Fraction: Uncovering the Consequences of an Overlooked Comorbidity</dc:title>
<dc:identifier>pmid:39652649</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.072220</dc:identifier>
</item>
<item>
<title>Letter by Huang et al Regarding Article, "Atherosclerosis Is a Smooth Muscle Cell-Driven Tumor-Like Disease"</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39652648/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241211072211&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Dec 10;150(24):e517-e518. doi: 10.1161/CIRCULATIONAHA.124.070427. Epub 2024 Dec 9.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39652648/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241211072211&v=2.18.0.post9+e462414">39652648</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.070427>10.1161/CIRCULATIONAHA.124.070427</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39652648</guid>
<pubDate>Mon, 09 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Huixin Huang</dc:creator>
<dc:creator>Xuqi Yang</dc:creator>
<dc:creator>Kai Yang</dc:creator>
<dc:date>2024-12-09</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Letter by Huang et al Regarding Article, "Atherosclerosis Is a Smooth Muscle Cell-Driven Tumor-Like Disease"</dc:title>
<dc:identifier>pmid:39652648</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.070427</dc:identifier>
</item>
<item>
<title>Precision Medicine in People at Risk for Diabetes and Atherosclerotic Cardiovascular Disease: A Fresh Perspective on Prevention</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39652647/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241211072211&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Dec 10;150(24):1910-1912. doi: 10.1161/CIRCULATIONAHA.124.070463. Epub 2024 Dec 9.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39652647/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241211072211&v=2.18.0.post9+e462414">39652647</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.070463>10.1161/CIRCULATIONAHA.124.070463</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39652647</guid>
<pubDate>Mon, 09 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Andreas L Birkenfeld</dc:creator>
<dc:creator>Paul W Franks</dc:creator>
<dc:creator>Viswanathan Mohan</dc:creator>
<dc:date>2024-12-09</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Precision Medicine in People at Risk for Diabetes and Atherosclerotic Cardiovascular Disease: A Fresh Perspective on Prevention</dc:title>
<dc:identifier>pmid:39652647</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.070463</dc:identifier>
</item>
<item>
<title>A Polygenic Predictor of Baseline QTc is Associated With Sotalol-Induced QT Prolongation</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39652646/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241211072211&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Dec 10;150(24):1984-1986. doi: 10.1161/CIRCULATIONAHA.124.070337. Epub 2024 Dec 9.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39652646/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241211072211&v=2.18.0.post9+e462414">39652646</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.070337>10.1161/CIRCULATIONAHA.124.070337</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39652646</guid>
<pubDate>Mon, 09 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Megan C Lancaster</dc:creator>
<dc:creator>Giovanni Davogustto</dc:creator>
<dc:creator>Edi Prifti</dc:creator>
<dc:creator>Claire Perret</dc:creator>
<dc:creator>Christian Funck-Brentano</dc:creator>
<dc:creator>Dan M Roden</dc:creator>
<dc:creator>Joe-Elie Salem</dc:creator>
<dc:date>2024-12-09</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>A Polygenic Predictor of Baseline QTc is Associated With Sotalol-Induced QT Prolongation</dc:title>
<dc:identifier>pmid:39652646</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.070337</dc:identifier>
</item>
<item>
<title>Scientific and Clinical Impacts of UK Biobank in Cardiovascular Medicine</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39652645/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241211072211&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Dec 10;150(24):1907-1909. doi: 10.1161/CIRCULATIONAHA.124.072449. Epub 2024 Dec 9.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39652645/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241211072211&v=2.18.0.post9+e462414">39652645</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.072449>10.1161/CIRCULATIONAHA.124.072449</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39652645</guid>
<pubDate>Mon, 09 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Adam J Lewandowski</dc:creator>
<dc:creator>Martin K Rutter</dc:creator>
<dc:creator>Rory Collins</dc:creator>
<dc:date>2024-12-09</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Scientific and Clinical Impacts of UK Biobank in Cardiovascular Medicine</dc:title>
<dc:identifier>pmid:39652645</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.072449</dc:identifier>
</item>





























</channel>
</rss>